Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with -$71.5 million as the latest value for Q3 2025.

  • Quarterly Change in Acquisitions & Divestments fell 87.1% to -$71.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $33.3 million through Jun 2025, down 12.9% year-over-year, with the annual reading at $22.8 million for FY2023, 81.56% up from the prior year.
  • Change in Acquisitions & Divestments hit -$71.5 million in Q3 2025 for Perspective Therapeutics, down from $49.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $49.8 million in Q2 2025 to a low of -$71.5 million in Q3 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $5.0 million across 4 years, with a median of $21.7 million in 2025.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 30.32% in 2025; the steepest drop was 87.1% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $12.5 million in 2022, then soared by 81.56% to $22.8 million in 2023, then plummeted by 267.92% to -$38.2 million in 2024, then plummeted by 87.1% to -$71.5 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for CATX at -$71.5 million in Q3 2025, $49.8 million in Q2 2025, and $21.7 million in Q1 2025.